云开药网品牌怎么样 申请店铺

我要投票 云开药网在网上药店行业中的票数:62 更新时间:2024-12-22
云开药网是哪个国家的品牌?「云开药网」是 浙江云开亚美大药房连锁有限公司 旗下著名品牌。该品牌发源于浙江,由创始人刘云江在2012-01-05期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
云开药网怎么样

浙江云开亚美医药科技股份有限公司(以下简称云开亚美),成立于2011年,上市公司海正药业(股票代码600267)控股企业。是国内领先的重大慢性疾病用药连锁专科药房,旗下有浙江云开亚美大药房连锁有限公司、上海云开亚美大药房有限公司、上海医度迅健康咨询有限公司三大子公司,以经营专科药品为特色,是一家集网上药店、高端连锁、专业药师服务为一体的优秀的医药电商企业,志于打造成为中国专业的医药电子商务零售平台。

云开亚美作为一个针对重大慢性疾病用药的高端零售品牌,专营重大慢特疾病用药及产品(包括药品,保健品,医疗器械等),并基于强大的数据库管理能力和专业的药师服务团队,致力于为客户提供持续、专业的疾病管理服务。

从建立以来,云开亚美一直专注于重大慢性特殊疾病领域,专营慢特疾病用药及产品(包括药品,保健品,医疗器械等),并以专业的医药学知识和真诚服务,基于患者数据库管理,致力于为客户提供持续、专业的疾病管理服务,以人为本的服务理念获得顾客信赖。

所有药师都具有药学专业资格证书,其中拥有执业药师资格占30%,具有扎实的医药基础、优秀的职业素养并在各自领域积累了特有的丰富专科用药知识和经验,致力于提供专业、专精的服务

数十位专业药师免费在线咨询,量身定做电子药历,全程指导用药,并在饮食、运动、日常保健注意等方面给以合理、贴心的专业指导。不仅保证患者可以坚持正确的用药过程,在日常生活各个方面也是遵照科学的方法给予指导,帮助患者全面保持健康。

截止2016年6月,云开亚美已在互联网全渠道建设部署,包括自建交易电商平台(云开药网|无线网店|云开掌上药店APP)、第三方平台旗舰店(天猫、京东、一号店、818、八百方、京卫药房网等)、社交交易平台(微信交易账户网店、支付宝服务窗交易账号网店等),已形成了良好的口碑效应

云开亚美积累了近40种慢特疾病近2000万的慢特疾病患者数据,尤其在股骨头坏死、糖尿病、慢性肾病、慢性肝病等领域极具优势。

云开亚美采用独有的DTC(DirectToConsumer)患教平台,面向慢性特殊疾病终端患者,以数以千万级的详实的患者数据库为核心,通过DTC网站、呼叫中心、短信平台、直邮平台、患者俱乐部及网络互动六大信息沟通渠道,为患者提供国际领先的疾病贴身服务。

专业IT技术团队20人,自建独立订单系统EC-ERP、专业客服接待/呼叫系统、CRM用户管理系统、大型专业物流仓储系统,系统自动跟踪订单、管理后台数据化呈现,用户全程实时跟踪更清晰、更直观、更简单。


Zhejiang Yunkai Yamei Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Yunkai Yamei), founded in 2011, is a holding enterprise of Haizheng Pharmaceutical (Stock Code: 600267). It is a leading chain specialty pharmacy for major chronic diseases in China. It has three subsidiaries, namely Zhejiang Yunkai Yamei pharmacy chain Co., Ltd., Shanghai Yunkai Yamei pharmacy Co., Ltd. and Shanghai yiduxun Health Consulting Co., Ltd. It is an excellent pharmaceutical e-commerce enterprise integrating online pharmacy, high-end chain and professional pharmacist services with the characteristics of specialized drugs The company aims to build a professional pharmaceutical e-commerce retail platform in China. As a high-end retail brand for major chronic disease drugs, Yunkai Yamei specializes in major chronic disease drugs and products (including drugs, health products, medical devices, etc.), and is committed to providing customers with continuous and professional disease management services based on strong database management ability and professional pharmacist service team. Since its establishment, Yunkai Yamei has been focusing on the field of major chronic special diseases, specializing in drugs and products for chronic special diseases (including drugs, health care products, medical devices, etc.), providing continuous and professional disease management services for customers based on professional medical knowledge and sincere service, patient database management, and people-oriented service concept to win customers' trust 。 All pharmacists have pharmaceutical professional qualification certificates, of which 30% are licensed pharmacists. They have solid medical foundation, excellent professional quality and have accumulated unique and rich specialized drug knowledge and experience in their respective fields. They are committed to providing professional and professional services for dozens of professional pharmacists, free online consultation, customized electronic drug calendar, guiding drug use in the whole process, and drinking Food, sports, daily health care and other aspects to give reasonable and thoughtful professional guidance. Not only to ensure that patients can adhere to the correct medication process, in all aspects of daily life is also in accordance with scientific methods to give guidance to help patients to maintain overall health. As of June 2016, Yun Kai Asia and the United States have already deployed in the whole channel of the Internet, including self built trading platform (cloud pharmaceutical network, wireless Internet store, cloud open pocket pharmacy APP), third party platform flagship store (Tmall, Jingdong, No. 1 store, 818, eight hundred party, Jingwei pharmacy network, etc.), social trading platform (WeChat trading account shop, Alipay service window, transaction account shop, etc.) It has formed a good word-of-mouth effect. Yunkai Yamei has accumulated data of nearly 20 million patients with 40 kinds of chronic diseases, especially in the areas of femoral head necrosis, diabetes, chronic kidney disease, chronic liver disease and so on. Yunkai Yamei adopts the unique DTC (directtoconsumer) patient education platform for the terminal patients with chronic special diseases. With tens of millions of detailed patient databases as the core, it provides the patients with the world's leading disease intimate service through six information communication channels: DTC website, call center, SMS platform, direct mail platform, patient club and network interaction. There are 20 professional IT technical teams, with independent order system EC-ERP, professional customer service reception / call system, CRM user management system and large-scale professional logistics storage system. The system automatically tracks orders and manages the background data presentation. The real-time tracking of users is clearer, more intuitive and simpler.

本文链接: https://brand.waitui.com/30598aa74.html 联系电话:057181909763

千城特选小程序码

7×24h 快讯

新易盛:涉嫌违反限制性规定转让股票等行为 公司实际控制人高光荣被立案调查

新易盛公告,公司控股股东、实际控制人、董事长高光荣于2024年12月20日收到中国证券监督管理委员会签发的《立案通知书》,因“涉嫌违反限制性规定转让股票”等行为被立案调查。该事项现处于调查阶段,具体情况尚待有关部门的最终确认。高光荣因其个人转让股票事宜被立案调查,与公司经营无关,不会对公司产生影响,公司生产经营情况一切正常。公司将持续关注上述事项的进展情况,并严格按照有关法律、法规的规定和要求,及时履行信息披露义务。

56分钟前

高德地图首发全域车道级导航

12月21日,蔚来NIO DAY上,高德地图全域车道级导航同蔚来智能电动行政旗舰ET9合作亮相,这也是高德地图车机版首发全域车道级服务,即将在蔚来更多车型得到升级搭载。

56分钟前

香港财政司司长陈茂波:香港未来须推动更多跨境合作创新,进一步提升金融市场体量

香港财政司司长陈茂波12月22日在司长随笔中表示,香港未来必须推动更多制度创新、产品创新与跨境合作创新,例如开拓内地通过香港与更多新兴市场的联系,同时巩固好与传统市场的协作,进一步提升香港金融市场的体量、流动性,更好满足科技变革与地缘政局下企业与其他机构的筹融资需要,让香港国际金融中心内涵更丰富、优势更巩固、国际影响力更显著。(界面)

56分钟前

湖畔实验室发布2024年创新成果

36氪获悉,12月22日,湖畔实验室(数据科学与应用浙江省实验室)发布包括AI多癌早筛、气象大模型等在内的多项年度创新成果。实验室用前沿AI技术迎战医疗、能源、农业、集成电路等产业难题,部分成果达到国际领先水平,并实现快速的落地应用,构建起“科技+产业”的正循环。作为浙江由民企牵头建设的省实验室,湖畔实验室成立于2020年7月,依托阿里巴巴达摩院建设,聚焦数据科学与应用领域。大会上,湖畔实验室进行了年度教科人一体化优秀项目颁奖和国家级博士后工作站揭牌,并与杭州电子科技大学战略合作签约。

56分钟前

卡塔尔警告欧盟,欧盟新指令或致卡方停止向欧盟输送天然气

12月22日,卡塔尔能源事务国务大臣、卡塔尔能源公司总裁兼首席执行官萨阿德·卡比警告,欧盟新指令或导致卡塔尔停止向欧盟输送天然气。卡比说,如果欧盟实施《企业可持续发展尽职调查指令》,让卡塔尔能源公司损失5%的收入,那卡方宁愿不进入欧洲市场。他强调,他不是在虚张声势,因为卡塔尔能源公司的收入属于卡塔尔政府和人民,没有人会接受损失这么多资金。卡比称,欧盟应该对《企业可持续发展尽职调查指令》进行审查。欧盟理事会今年5月批准通过《企业可持续发展尽职调查指令》。该指令将在未来几年分阶段实施,对在欧盟运营的具有一定规模的企业引入强制性的环境尽职调查要求,旨在减轻或终止对环境造成的不利影响。对于违反该指令的企业,最高可被处以全球营业额5%的罚款。

56分钟前

本页详细列出关于广药健民的品牌信息,含品牌所属公司介绍,广药健民所处行业的品牌地位及优势。
咨询